Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1
ACTIVE INGREDIENTS: Water, Mineral Oil, Sorbitol, Petrolatum, Cetyl Alcohol, Dimethicone, Glyceryl Stearate, PEG-100 Stearate, Glycerin, Ethylhexyl Methoxycinnamate, Phenoxyethanol, Fragrance Carbomer, Methiparaben, Ethyparaben, Disodium EDTA, Potassium Hydroxide, Xanthan Gum, Tocopheryl Acetate, Hydrolyzed Milk Protein, Kojic Dipalmitate, Alcohol, Solanum Lycopersicum, (Tomato) Fruit Extract, Lacithin, Aloe Barbadansis Leaf Juice, Maltodextrin, tocopherol, Arbutin, Linolenic Acid, Glutathione, Ascorbyl
Established pharmacological options including acamprosate, naltrexone, and nalmefene remain the evidence-based first-line treatments
Ozempic is a modified form of GLP-1 with approximately 94% sequence homology to human GLP-1